Aepodia   Report issue

For profit Phase 1 Phase 3
Founded: Lovain Belgium (2007)

Organization Overview

First Clinical Trial
2016
NCT02609022
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Aepodia